Literature DB >> 14667223

Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors.

Haitao Ji1, Huiying Li, Mack Flinspach, Thomas L Poulos, Richard B Silverman.   

Abstract

Selective inhibition of nitric oxide synthase (NOS) isoforms has great therapeutic potential in the treatment of certain disease states arising from the pathological overproduction of nitric oxide. In this study three structures of each NOS isoform were employed to examine selective regions in the active site using the GRID/CPCA approach. In the GRID calculations, 10 probes covering hydrophobic, steric, and hydrogen-bond-acceptor and -donor interactions were used to calculate the molecular interaction fields (MIFs) in the active site. The side chain flexibility of the residues and the grid spacings were considered at the same time. Consensus principal component analysis (CPCA) was applied to analyze the MIFs differences in the active site between the NOS isoforms. By combining the cutout tool with GRID/CPCA pseudofield differential plots, several selective regions in the active site were identified. The selectivity analysis showed that the most important determinants for NOS inhibitor selectivity are hydrophobic and charge-charge interactions. Twenty-five inhibitors of NOS were then docked into the active site using the program AutoDock3.0. The regions identified as being important for selectivity by this method are in excellent agreement with inhibitor structure-activity relationships. A rational usage of the selective region described in this work should make it possible to develop NOS isoform-selective inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667223     DOI: 10.1021/jm030301u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

1.  Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies.

Authors:  Cristina Maccallini; Monica Montagnani; Roberto Paciotti; Alessandra Ammazzalorso; Barbara De Filippis; Mauro Di Matteo; Sara Di Silvestre; Marialuigia Fantacuzzi; Letizia Giampietro; Maria A Potenza; Nazzareno Re; Assunta Pandolfi; Rosa Amoroso
Journal:  ACS Med Chem Lett       Date:  2015-04-28       Impact factor: 4.345

2.  Structure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthase.

Authors:  Fengtian Xue; Jinwen Huang; Haitao Ji; Jianguo Fang; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2010-07-01       Impact factor: 3.641

3.  Peripheral but crucial: a hydrophobic pocket (Tyr(706), Leu(337), and Met(336)) for potent and selective inhibition of neuronal nitric oxide synthase.

Authors:  Fengtian Xue; Huiying Li; Jianguo Fang; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem Lett       Date:  2010-08-26       Impact factor: 2.823

4.  Conformationally restricted dipeptide amides as potent and selective neuronal nitric oxide synthase inhibitors.

Authors:  Haitao Ji; José A Gómez-Vidal; Pavel Martasek; Linda J Roman; Richard B Silverman
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

5.  Acid-Facilitated Debenzylation of N-Boc, N-Benzyl Double Protected 2-Aminopyridinomethylpyrrolidine Derivatives.

Authors:  Haitao Ji; Qing Jing; Jinwen Huang; Richard B Silverman
Journal:  Tetrahedron       Date:  2011-12-13       Impact factor: 2.457

6.  Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy.

Authors:  Haitao Ji; Sidhartha Tan; Jotaro Igarashi; Huiying Li; Matthew Derrick; Pavel Martásek; Linda J Roman; Jeannette Vásquez-Vivar; Thomas L Poulos; Richard B Silverman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

Review 7.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

8.  L337H mutant of rat neuronal nitric oxide synthase resembles human neuronal nitric oxide synthase toward inhibitors.

Authors:  Jianguo Fang; Haitao Ji; Graham R Lawton; Fengtian Xue; Linda J Roman; Richard B Silverman
Journal:  J Med Chem       Date:  2009-07-23       Impact factor: 7.446

9.  Discovery of highly potent and selective inhibitors of neuronal nitric oxide synthase by fragment hopping.

Authors:  Haitao Ji; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2009-02-12       Impact factor: 7.446

10.  Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.

Authors:  Elsa D Garcin; Andrew S Arvai; Robin J Rosenfeld; Matt D Kroeger; Brian R Crane; Gunilla Andersson; Glen Andrews; Peter J Hamley; Philip R Mallinder; David J Nicholls; Stephen A St-Gallay; Alan C Tinker; Nigel P Gensmantel; Antonio Mete; David R Cheshire; Stephen Connolly; Dennis J Stuehr; Anders Aberg; Alan V Wallace; John A Tainer; Elizabeth D Getzoff
Journal:  Nat Chem Biol       Date:  2008-10-12       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.